Mesoblast
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 |
|---|---|---|
Revenue | $7,021 | $7,021 |
Gross Profit | -16,227 | -16,227 |
EBITDA | -19,636 | -19,636 |
EBIT | -21,229 | -21,229 |
Net Income | -27,104 | -27,104 |
Net Change In Cash | 7,021 | 7,021 |
Free Cash Flow | -14,936 | -12,808 |
Cash | 161,158 | 161,551 |
Basic Shares | 127,328 | 127,328 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $17,198 | $5,902 | $7,501 | $10,211 |
Gross Profit | 12,068 | -35,168 | -47,421 | -53,361 |
EBITDA | -73,659 | -56,077 | -58,550 | -76,573 |
EBIT | -80,059 | -57,972 | -62,657 | -80,953 |
Net Income | -102,142 | -87,956 | -81,889 | -91,347 |
Net Change In Cash | 17,198 | 5,902 | 7,501 | 10,211 |
Free Cash Flow | -50,684 | -48,789 | -63,583 | -66,014 |
Cash | 161,158 | 62,563 | 70,920 | 60,034 |
Basic Shares | 120,779 | 98,670 | 83,926 | 68,286 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.07 |
2025-06-30 | -$0.04 |
2025-03-31 | $0 |
